Role of thyroid hormone during early brain development

被引:490
作者
de Escobar, GM [1 ]
Obregón, MJ [1 ]
del Rey, FE [1 ]
机构
[1] Univ Autonoma Madrid, CSIC, Inst Investigac Biomed Alberto Sols, Madrid 28029, Spain
关键词
D O I
10.1530/eje.0.151u025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present comments are restricted to the role of maternal thyroid hormone on early brain development, and are based mostly on information presently available for the human fetal brain. It emphasizes that maternal hypothyroxinemia - defined as thyroxine (T4) concentrations that are low for the stage of pregnancy - is potentially damaging for neurodevelopment of the fetus throughout pregnancy, but especially so before midgestation, as the mother is then the only source of T4 for the developing brain. Despite a highly efficient uterine-placental 'barrier' to their transfer, very small amounts of T4 and triiodothyronine (T3) of maternal origin are present in the fetal compartment by 4 weeks after conception, with T4 increasing steadily thereafter. A major proportion of T4 in fetal fluids is not protein-bound: the 'free' T4 (FT4) available to fetal tissues is determined by the maternal serum T4, and reaches concentrations known to be of biological significance in adults. Despite very low T3 and 'free' T3 (FT3) in fetal fluids, the T3 generated locally from T4 in the cerebral cortex reaches adult concentrations by midgestation, and is partly bound to its nuclear receptor. Experimental results in the rat strongly support the conclusion that thyroid hormone is already required for normal corticogenesis very early in pregnancy. The first trimester surge of maternal FT4 is proposed as a biologically relevant event controlled by the conceptus to ensure its developing cerebral cortex is provided with the necessary amounts of substrate for the local generation of adequate amounts of T3 for binding to its nuclear receptor. Women unable to increase their production of T4 early in pregnancy would constitute a population at risk for neurological disabilities in their children. As mild-moderate iodine deficiency is still the most widespread cause of maternal hypothyroxinemia in Western societies, the birth of many children with learning disabilities may already be preventable by advising women to take iodine supplements as soon as pregnancy starts, or earlier if possible.
引用
收藏
页码:U25 / U37
页数:13
相关论文
共 64 条
[1]   Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism [J].
Alexander, EK ;
Marqusee, E ;
Lawrence, J ;
Jarolim, P ;
Fischer, GA ;
Larsen, PR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (03) :241-249
[2]  
[Anonymous], THYR BRAIN MERCK EUR
[3]   Fetal loss associated with excess thyroid hormone exposure [J].
Anselmo, J ;
Cao, DC ;
Karrison, T ;
Weiss, RE ;
Refetoff, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (06) :691-695
[4]   Resistance to thyroid hormone does not abrogate the transient thyrotoxicosis associated with gestation: Report of a case [J].
Anselmo, J ;
Kay, T ;
Dennis, K ;
Szmulewitz, R ;
Refetoff, S ;
Weiss, RE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4273-4275
[5]   Neonatal hypothyroxinemia: Effects of iodine intake and premature birth [J].
Ares, S ;
EscobarMorreale, HF ;
Quero, J ;
Duran, S ;
Presas, MJ ;
Herruzo, R ;
deEscobar, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1704-1712
[6]   INVERSE RELATION BETWEEN IODINE INTAKE AND THYROID BLOOD-FLOW - COLOR DOPPLER FLOW IMAGING IN EUTHYROID HUMANS [J].
ARNTZENIUS, AB ;
SMIT, LJ ;
SCHIPPER, J ;
VANDERHEIDE, D ;
MEINDERS, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) :1051-1055
[7]   A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration [J].
Ausó, E ;
Lavado-Autric, R ;
Cuevas, E ;
del Rey, FE ;
de Escobar, GM ;
Berbel, P .
ENDOCRINOLOGY, 2004, 145 (09) :4037-4047
[8]   MATURATION OF THYROID-FUNCTION IN NORMAL HUMAN FETUSES [J].
BALLABIO, M ;
NICOLINI, U ;
JOWETT, T ;
DEELVIRA, MCR ;
EKINS, RP ;
RODECK, CH .
CLINICAL ENDOCRINOLOGY, 1989, 31 (05) :565-571
[9]  
Barnett C.A., 1999, J ENDOCRINOLOGICAL I, V25, P90
[10]  
BECKPECCOZ P, 1992, ACTA MED AUST, V19, P72